September 30th 2024
The event will focus on innovating with cutting-edge technology, featuring the likes of pharmaceutical technology companies revolutionizing the industry.
Who should pay for HPV vaccine—the costliest vaccine to date?
June 4th 2007The emergence of any vaccine is a complicated event, necessitating physician, pharmacist, and public education and the creation of formulary protocols. But when a drug directly involves issues surrounding the sexual activity of underage girls, complexity devolves into controversy.
Wolters Kluwer releases Trissel's IV-check APIv3.1
May 28th 2007Wolters Kluwer Health announced the introduction of Trissel's IV-CHEK API v3.1 (Trissel's IV-CHECK), which combines data from Trissel's 2, with Medi-Span integrated software. The combination will enable clinicians to access parenteral drug compatibility information from within their professional work flow computer systems.
NACDS calls for legislation targeting rogue Internet drug sellers
May 28th 2007In comments filed with the Senate Judiciary Committee, NACDS reported that it is "greatly concerned" about the threat to patient safety posed by rogue Internet sites and wants to work with Congress to eliminate illegal Internet sites from the market.
Michigan AG finds drug price variations
May 28th 2007The investigation looked at prices at 200 pharmacies in nine communities for 11 medications not currently listed on the site. The investigation found price differences of nearly $100 for prescriptions of Ambien (zolpidem, Sanofi-Aventis) in Detroit and Lansing.
New protocol for handling EGFR inhibitor skin reactions
May 28th 2007An article in the May 2007 issue of The Oncologist proposes a new system for handling skin toxicities associated with epidermal growth factor receptor (EGFR) inhibitors, an adverse reaction that ranges in type and severity and occurs in more than half of treated patients.